Suchergebnisse
Suchergebnisse:
2010 Senior Vice President, BioOncology Business Unit, Genentech, USA. 2013 Global Product Strategy Head/Chief Marketing Officer, Roche Pharmaceuticals, Basel, Switzerland. 2016 Head of North American Operations, Genentech, USA. 2017-2018 Chief Executive Officer, Genentech, USA.
31. Mai 2023 · Avant cela, Bill Anderson était CEO de Genentech, l'une des sociétés pionnières dans le domaine de la biotechnologie. « Nous sommes ravis d'accueillir Bill Anderson en tant que nouveau CEO de Bayer. Il est le candidat idéal pour diriger Bayer vers un nouveau chapitre. Bill a une expérience exceptionnelle dans la construction de solides ...
Ashley Magargee Chief Executive Officer, Genentech. Aviv Regev Executive Vice President, Research and Early Development, Genentech. Levi Garraway Chief Medical Officer, Executive Vice President and Head of Global Product Development, Roche and Genentech. Alan Hippe Chief Financial Officer, Roche Group. Richard Lifton President, The Rockefeller ...
Bayer. Roche. Genentech. Children. 3. William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023. [1] [2] Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche 's Pharmaceuticals Division from 2019 to 2022.
12. Dez. 2022 · Bill Anderson, the former boss of Roche's Genentech unit, would quit at the end of the year "to pursue opportunities outside of Roche", with a successor due to be named by March 2023, Roche said ...
7. Sept. 2023 · In 2016, he moved back to Genentech to assume the position of Head of North American Operations before becoming CEO of the company in 2017. In 2019, Bill became CEO of Roche Pharmaceuticals based in Switzerland. Bill Anderson is married and has three adult children. Follow Bill Anderson on LinkedIn
10. Feb. 2023 · So tickt der neue Bayer-CEO Bill Anderson. Der neue Bayer-CEO hat seine Karriere bei Top-Biotechfirmen in den USA verbracht. Überzeugt hat er die Aufsichtsräte nicht allein wegen seiner ...
